Skip to main content
Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Upadacitinib Proves Successful in First JAK Inhibitor Trial for Giant Cell Arteritis
User login
Username
Password
Reset your password
Concept
Lead
score
Vasculitis
1
1
Remission
0
0.67
Rheumatoid Arthritis
0
0.62
Giant Cell Arteritis
0
0.99
Glucocorticoid
0
0.33
Arthritis
0
0.25
Thromboembolism
0
0.22
Europe
0
0.17
Steroids
0
0.17
Biologic Therapy
0
0.13
Adherence
0
0.08
Concerns of Elderly
0
0.08
Cytokines
0
0.08
Fatigue
0
0.08
Geriatrics
0
0.08
Grant
0
0.08
Hospital
0
0.08
Interleukin
0
0.08
Italy
0
0.08
Pathogenesis
0
0.08
Venous Thromboembolism (VTE)
0
0.08
Specialty
Lead
score
Rheumatology
1
1
Internal Medicine
0
0.9
Edit Tags